A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.
Also called NCT02358343
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 184 participants
- Sponsor
- Registry
-
NCT02358343
-
- Other papers using this trial's data
- Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02358343. Randomized; no masking; primary purpose treatment. Start 2015-03-23 (actual); primary completion 2017-11-15 (actual). Results posted on 2019-07-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
- Acronym
- ASCEND
- Condition
- Depression
- Condition
- End Stage Renal Disease
- Intervention (Behavioral)
- Engagement Interview
- Intervention (Behavioral)
- Cognitive Behavioral Therapy
- Intervention (Drug)
- Antidepressant Drug Therapy
- Lead sponsor
- University of Washington
- Collaborator
- University of Texas
- Collaborator
- University of New Mexico
- Collaborator
- Patient-Centered Outcomes Research Institute
Record details
- Record id
cardio:ct-nct02358343- Content hash
dc343075333d6f06e823a1557c56545f14a3eb15ce017024ba79d2f65712f28d